Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: A practical and clinically relevant approach in a large cohort

Journal of Clinical Laboratory Analysis

Volumn 20, Issue 5, 2006, Pages 209-217

  Ritchie, Robert F ^a   Palomaki, Glenn E ^a   Neveux, Louis M ^a   Ledue, Thomas B ^a   Craig, Wendy Y ^a   Marcovina, Santica ^b   Navolotskaia, Olga ^c  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apolipoprotein AI; Apolipoprotein B; Apolipoprotein B AI ratio; Caucasian; Reference intervals; Reference Material SP1 01; Reference Material SP3 07

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHILD; CLINICAL LABORATORY; COHORT ANALYSIS; DEVICE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PATIENT CODING; PERIPHERAL VASCULAR DISEASE; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEX DIFFERENCE; SYMPTOMATOLOGY; UNITED STATES;

AGE DISTRIBUTION; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE STANDARDS; REGRESSION ANALYSIS; SEX DISTRIBUTION;

EID: 33748758187     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20134     Document Type: Article

References (24)

1. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem 1994;40:586-592.
2. International Federation of Clinical Chemistry and Laboratory Medicine. Reference Materials. Apolipoprotein AI. http://ifcc.org/products/reference/sp1. htm.
3. International Federation of Clinical Chemistry and Laboratory Medicine. Reference Materials. Apolipoprotein B. http://ifcc.org/products/reference/sp3. htm.
4. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 1998;12:363-370.
5. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999;13:273-279.
6. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 2000;14:284-292.
7. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 2002;16:237-245.
8. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:1-8.
9. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for alpha2-macroglobulin: A practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:139-147.
10. Ritchie RF, Palomaki GE, Neveux LM, Ledue TB, Marcovina S, Navolostkaia O. Reference distributions for apolipoproteins AI and B and B/AI ratios: a comparison of a large cohort to the world's literature. J Clin Lab Anal 2006;20:218-226.
11. Healy MJ. Outliers in clinical chemistry quality-control schemes. Clin Chem 1979;25:675-77.
12. Palomaki GE, Neveux LM. Using multiples of the median to normalize serum protein measurements. Clin Chem Lab Med 2001;39:1137-1145.
13. Ledue TB, Johnson AM, Cohen LA, Ritchie RF. Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem 1998;44:878-879.
14. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
15. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR. Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 1992;32:1035-1041.
16. Maes M, Wauters A, Neels H, et al. Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity. J Affect Disord 1995;34:61-69.
17. Song CS, Merkatz IR, Rifkind AB, Gillette PN, Kappas A. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Studies with a quantitative immunodiffusion method. Am J Obstet Gynecol 1970;108:227-231.
18. Dotchev D, Liappis N, Hungerland H. Sex-specific differences of serum proteins in adults and influence of oral hormonal contraceptives on serum protein composition. Clin Chim Acta 1973;44:431-435.
19. Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983;90:139-145.
20. Navolotskaia O. Pregnancy/hormone effect. In: Ritchie RF, Navolotskaia O, editors. Serum proteins in clinical medicine, clinical section, vol. 2. Scarborough, ME: Foundation for Blood Research; 1999. p 106.100.101-106.100.111.
21. Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002;106:1447-1452.
22. Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients. Atherosclerosis 2002;164:361-369.
23. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. Villanova, PA: NCCLS; 1995. 1-59. NCCLS Document C28-A (ISBN 1-56238-269-1).
24. Gräsbeck R SG, Wilding P, Williams GZ, Whitehead TP. Provisional recommendation on the theory of reference values. Part 1. The concept of reference values. Clin Chim Acta 1978;87:461F-465F.